| Literature DB >> 16713726 |
Sophie Payot1, Jean-Michel Bolla, Deborah Corcoran, Séamus Fanning, Francis Mégraud, Qijing Zhang.
Abstract
The incidence of human Campylobacter infections is increasing worldwide, as well as the proportion of isolates resistant to fluoroquinolones and/or macrolides, the drugs of choice to treat campylobacteriosis. In this review, we report recent developments in the understanding of the resistance mechanisms to fluoroquinolones and macrolides. In addition, we will discuss the recent findings on multidrug resistance in Campylobacter spp.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16713726 DOI: 10.1016/j.micinf.2005.12.032
Source DB: PubMed Journal: Microbes Infect ISSN: 1286-4579 Impact factor: 2.700